CENIMAT-i3N, Departamento de Ciência dos Materiais, Faculdade de Ciências e Tecnologia, FCT, Universidade Nova de Lisboa, and CEMOP/UNINOVA, 2829-516 Caparica, Portugal.
Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal.
Analyst. 2023 Aug 21;148(17):4053-4063. doi: 10.1039/d3an00971h.
Early and accurate detection of infection by pathogenic microorganisms, such as Plasmodium, the causative agent of malaria, is critical for clinical diagnosis and ultimately determines the patient's outcome. We have combined a polystyrene-based microfluidic device with an immunoassay which utilises Surface-Enhanced Raman Spectroscopy (SERS) to detect malaria. The method can be easily translated to a point-of-care testing format and shows excellent sensitivity and specificity, when compared to the gold standard for laboratorial detection of Plasmodium infections. The device can be fabricated in less than 30 min by direct patterning on shrinkable polystyrene sheets of adaptable three-dimensional microfluidic chips. To validate the microfluidic system, samples of -infected red blood cell cultures were used. The SERS-based immunoassay enabled the detection of 0.0012 ± 0.0001% parasitaemia in a -infected red blood cell culture supernatant, an ∼7-fold higher sensitivity than that attained by most rapid diagnostic tests. Our approach successfully overcomes the main challenges of the current detection methods, including increased reproducibility, sensitivity, and specificity. Furthermore, our system can be easily adapted for detection of other pathogens and has excellent properties for early diagnosis of infectious diseases, a decisive step towards lowering their high burden on healthcare systems worldwide.
早期、准确地检测致病性微生物(如疟原虫)的感染对于临床诊断至关重要,最终决定了患者的结局。我们将基于聚苯乙烯的微流控设备与免疫测定法相结合,该免疫测定法利用表面增强拉曼光谱(SERS)检测疟疾。与实验室检测疟原虫感染的金标准相比,该方法易于转化为即时检测格式,具有出色的灵敏度和特异性。该设备可通过直接在可收缩的聚苯乙烯片上图案化来在不到 30 分钟的时间内制造出适应性强的三维微流控芯片。为了验证微流控系统,我们使用了感染的红细胞培养物样本。基于 SERS 的免疫测定法能够检测到感染的红细胞培养上清液中 0.0012 ± 0.0001%的疟原虫血症,灵敏度比大多数快速诊断测试高约 7 倍。我们的方法成功克服了当前检测方法的主要挑战,包括提高了重现性、灵敏度和特异性。此外,我们的系统可以轻松适应其他病原体的检测,并且具有早期诊断传染病的出色性能,这是降低全球医疗保健系统传染病高负担的关键步骤。